,trastuzumab deruxtecan
astrazeneca,daiichi sankyo
['bcsm', 'breast', 'enhertu']
enhertu could transform #breastcancer treatment, landmark her2-low trial suggests. #asco22 #bcsm
Medscape provides breaking medical news and expert perspectives, drug and disease information, and free CME across 30+ medical specialties.